Winstrol 50 Inj

Dragon Pharma Winstrol Inj 50 — Injectable Stanozolol for Contest Prep

Dragon Pharma Winstrol Inj 50 is a water-based injectable suspension delivering 50 mg of Stanozolol per milliliter. This parenteral formulation is engineered for athletes seeking a dry, grainy, and competition-ready physique without subcutaneous water retention.

The compound binds aggressively to androgen receptors while simultaneously lowering Sex Hormone-Binding Globulin. This dual action amplifies free testosterone availability and produces the hardened, vascular aesthetic prized during pre-contest phases.

Overview

Stanozolol is a synthetic DHT analogue with a pyrazole ring fused to the A-ring. This modification delivers high anabolic activity with minimal androgenic expression and zero aromatization potential.

The injectable water suspension bypasses gastrointestinal degradation. It achieves stable plasma concentrations without the hepatic first-pass burden associated with oral tablets, though hepatotoxicity remains a relevant consideration.

Dragon Pharma manufactures each 10 mL vial under stringent aseptic conditions. Independent laboratory analysis verifies potency, sterility, and absence of particulate contamination.

With an active half-life of approximately 24 hours, daily or every-other-day administration maintains consistent receptor saturation. This supports sustained strength output and metabolic enhancement throughout the cutting protocol.

Benefits

• Extreme Muscular Hardness: Expels interstitial fluid from subcutaneous tissue, creating a dense, grainy appearance with visible striations and separation.
• Amplified Vascularity: Reduces adipose thickness and water retention, dramatically enhancing superficial vein prominence across the physique.
• Dry Strength Retention: Supports explosive power output without the rapid weight spikes or bloating characteristic of wet compounds. Ideal for caloric deficit training.
• SHBG Reduction: Lowers circulating Sex Hormone-Binding Globulin, increasing the concentration of bioavailable, unbound testosterone and other anabolic hormones.
• Zero Estrogenic Activity: As a non-aromatizing DHT derivative, Stanozolol cannot convert to estradiol. Users avoid gynecomastia, edema, and estrogen-mediated hypertension.

Main Features

• Water-based injectable suspension at 50 mg/mL concentration
• Dihydrotestosterone-derived anabolic with no aromatization
• Bypasses first-pass hepatic metabolism relative to oral delivery
• Approximately 24-hour active half-life
• Compatible with oil-based compounds in mixed injection protocols
• Independent third-party verification of potency and sterility

Ingredients

Each milliliter contains 50 mg of Stanozolol as the active pharmaceutical ingredient.

The aqueous suspension utilizes sterile water for injection, benzyl alcohol as a preservative, and stabilizing agents to maintain particulate dispersion. All raw materials are validated for identity and purity prior to compounding.

How to Use

Administer via deep intramuscular injection using a sterile 1-inch to 1.5-inch needle. Rotate sites between the gluteal muscles, vastus lateralis, and deltoids to prevent localized tissue irritation.

As a water-based solution, shaking the vial before drawing is essential to ensure uniform suspension of the active microparticles. Warm the vial to room temperature to reduce injection discomfort.

Maintain strict aseptic technique. Cleanse the rubber septum with isopropyl alcohol before each access. Aspirate prior to plunging to confirm extravascular placement. Never share injection equipment.

Store unopened vials in a cool, dark environment between 15–25°C (59–77°F). Do not freeze. Once punctured, use within 28 days to ensure sterility.

Dosage

Male beginners should initiate at 25–50 mg every other day. This equates to approximately 75–150 mg weekly and allows for tolerance assessment.

Intermediate and advanced male athletes may increase to 50 mg daily. Alternatively, 75–100 mg every other day delivers approximately 350–400 mg weekly for more aggressive conditioning.

Female athletes must exercise extreme caution due to virilization risk. A maximum of 5–10 mg every other day is the upper threshold, with close monitoring for irreversible masculinization signs.

Limit continuous administration to 6–8 weeks. Extended exposure significantly amplifies hepatotoxic and cardiovascular risks.

Side Effects

Hepatotoxicity remains the primary safety concern. Despite bypassing initial first-pass metabolism, Stanozolol is C17-alpha alkylated and imposes strain on hepatic enzymes.

Regular liver function panels are mandatory. Hepatoprotective supplementation with TUDCA and N-acetylcysteine should accompany every cycle. Alcohol and acetaminophen are strictly contraindicated.

The profound drying effect frequently compromises synovial lubrication. Users commonly report elbow, knee, or shoulder discomfort during heavy compound movements.

Stanozolol exerts a severe negative impact on lipid profiles. It typically suppresses HDL cholesterol while elevating LDL. Cardiovascular support through omega-3 fatty acids, soluble fiber, and regular aerobic exercise is essential.

Androgenic manifestations including acne, accelerated scalp hair thinning in predisposed individuals, and increased sebum production may emerge at higher dosages.

All exogenous androgens suppress hypothalamic-pituitary-gonadal axis function. Endogenous testosterone production declines during the cycle, necessitating a structured recovery phase.

Safety Information

This product is intended exclusively for research purposes and use by qualified adults. It is not suitable for minors, pregnant or nursing women, or individuals with pre-existing hepatic, cardiovascular, or renal pathology.

A comprehensive Post-Cycle Therapy protocol using Clomiphene or Tamoxifen must begin 2–3 days after the final injection. This restores natural testosterone synthesis and prevents prolonged hypogonadal symptoms.

Maintain a heart-healthy diet rich in omega-3 fatty acids and low in saturated fats throughout the cycle. Regular cardiovascular exercise supports vascular health and lipid management.

Avoid all hepatotoxic substances during the active phase. Discontinue immediately and seek medical evaluation if jaundice, severe abdominal pain, dark urine, or persistent fatigue develop.